What Is the Treatment of Peritoneal Tuberculosis?

Clinical Overview

Peritoneal tuberculosis is a form of extrapulmonary tuberculosis affecting the peritoneum. Like other forms of extrapulmonary TB, it requires a structured, evidence-based antitubercular regimen. The protocol outlined here follows the same treatment principles applied to pulmonary TB disease.

Treatment Approach

Management involves a full course of antitubercular therapy delivered in two distinct phases — an intensive phase followed by a continuation phase. The phased structure of the regimen reflects current evidence for abdominal and peritoneal TB.

The specific drug combination, phase durations, and adjustments for recurrent or complicated disease are detailed in the full protocol →
Instant Access to Structured Evidence-Based Regimens

References

  1. Patients with abdominal TB should receive a full course of antitubercular therapy.
  2. A 2-month course of treatment as detailed in Table 8 is currently recommended for uncomplicated ITB.
  3. Extrapulmonary TB should be treated using the same antituberculous drug regimens as pulmonary TB disease.
  4. A Cochrane review found no evidence to suggest that 6-month treatment regimens are inadequate for treating people who have intestinal and peritoneal TB, but the numbers are small.
View source ↗